VP, DM1 Commercial Asset Lead
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
31 live vacancies in the US.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.